Daiichi Jitsugyo Co (8059) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
15 May, 2026Executive summary
Achieved record-high profits at all levels for FY2025 despite a 2.614 billion yen decrease in net sales year-over-year.
Operating profit rose by 593 million yen YoY to 13.696 billion yen, and ordinary profit increased by 755 million yen to 14.353 billion yen.
Profit attributable to owners increased by 1.110 billion yen to 9.951 billion yen, with comprehensive income up 62.9% to 14.039 billion yen YoY.
Cash and cash equivalents at year-end increased to 51.829 billion yen, up 17.946 billion yen YoY, reflecting strong operating cash flow.
EPS increased by 33.20 yen YoY to 311.77 yen.
Financial highlights
Net sales for FY2025 were 219.140 billion yen, down from 221.755 billion yen in FY2024.
Gross profit increased by 1.338 billion yen YoY to 39.109 billion yen.
Equity ratio increased to 51.5% from 46.5% YoY.
Net assets per share climbed to 2,834.14 yen from 2,499.41 yen.
Dividend per share for FY2026 was 125 yen, up from 92 yen, with a payout ratio of 40.1%.
Outlook and guidance
FY2026 net sales are forecast at 210 billion yen amid a highly uncertain business environment.
Operating profit is projected at 12 billion yen, and profit attributable to owners at 9.4 billion yen for FY2026.
Annual dividend forecast for FY2026 is 125 yen per share, with an interim dividend of 62 yen.
FY2027 forecast: ordinary profit 12.4 billion yen, EPS 294.40 yen, payout ratio 42.5%.
Latest events from Daiichi Jitsugyo Co
- Record Q3 profits and strong segment growth support an upwardly revised full-year outlook.8059
Q3 20264 Feb 2026 - Record Q2 sales and profits led to upward revisions in full-year forecasts and dividends.8059
Q2 20267 Nov 2025 - Record-high sales and profit, improved equity ratio, and strong full-year outlook.8059
Q2 20259 Sep 2025 - Record Q3 sales and profits, stock split, and strong growth across all segments.8059
Q3 20259 Sep 2025 - Record sales and profits, strong overseas growth, and a conservative outlook for next year.8059
Q4 20259 Sep 2025 - Record Q1 sales and profits driven by Healthcare and Automobile, but outlook is slightly cautious.8059
Q1 20269 Sep 2025 - Strong sales and profit growth, with robust outlook and improved equity ratio.8059
Q1 20259 Sep 2025